Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.22.2
Stockholders’ Equity (Tables)
6 Months Ended
Jun. 30, 2022
Equity [Abstract]  
Schedule of Stock Options Activity

The following table summarizes stock options activity during the six months ended June 30, 2022 for the 2022 Plan, the 2022 Directors’ Plan, the 2018 Stock Plan and the Inducement Awards (in thousands, except per share data).

 

    Number
of Shares
   

Weighted
Average
Exercise Price

   

Weighted
Average

Remaining

Contractual Life

(in years)

    Total
Intrinsic Value
 
Outstanding as of January 1, 2022     5,110     $ 3.27       3.4     $ 20,820  
Granted     400       6.44       7.0       -  
Cashless exercised     (570 )     2.66       -       -  
Forfeited     (20 )     2.87       -       -  
Outstanding as of June 30, 2022     4,920     $ 3.30       3.3     $ 46,159  
Options vested and exercisable     3,662     $ 2.31       2.3     $ 37,972  
Summary of Weighted Average Assumptions Used in Determining Fair Value of Warrants

The following table summarizes weighted average assumptions used in determining the fair value of the options at the date of grant during the six months ended June 30, 2022 and 2021:

 

    For the six months ended  
    June 30,  
    2022     2021  
Exercise price   $ 6.74     $ 9.13  
Expected term (years)     4.8       3.5  
Expected stock price volatility     77 %     83 %
Risk-free rate of interest     3.0 %     0.6 %
Expected dividend yield (per share)     0 %     0 %
Schedule of Warrant Activity

The following table summarizes warrant activity during the six months ended June 30, 2022 (in thousands, except per share data):

 

    Number of Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Life
(in years)
 
Outstanding as of January 1, 2022     855     $ 8.23       1.9  
Warrants granted     -       -       -  
Outstanding as of June 30, 2022     855     $ 8.23       1.4  
Warrants vested and exercisable     855     $ 8.23       1.4